Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
5.52
0.03 (0.64%)
At close: Aug 18, 2025, 3:59 PM
5.52
0.00%
After-hours: Aug 18, 2025, 04:10 PM EDT

Silence Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.17 -11.71 -10.02 -13.28
PEG Ratio
0.44 1.64 2.21 -1.33
PS Ratio
7.51 19.96 23.19 42.15
PB Ratio
2.42 29.71 18.39 61.38
P/FCF Ratio
-4.79 -12.86 -8.84 95.64
P/OCF Ratio
-4.8 -12.87 -8.93 76.90
OCF/S Ratio
-1.56 -1.55 -2.6 0.55
Debt / Equity Ratio
0.00 0.02 0.02 0.02
Quick Ratio
11.14 4.56 5.15 5.69
Current Ratio
11.14 4.56 4.41 5.69
Asset Turnover
0.21 0.27 0.16 0.13
Interest Coverage
n/a -1.46K -1.03K -5.73K
Return on Equity
-0.34 -2.54 -1.83 -4.62
Return on Assets
-0.22 -0.46 -0.38 -0.41
Return on Invested Capital
-0.35 -0.56 -0.48 -0.49
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.73 0.59 0.38 0.40
Net Profit Margin
-1.05 -1.71 -2.31 -3.17
Pretax Profit Margin
-1.03 -1.98 -2.71 -3.69
Operating Profit Margin
-1.46 -1.95 -2.78 -3.69
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.13 -1.96 -2.74 -3.66